Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to $3.4 million.

  • Palisade Bio's Cash from Financing Activities rose 196833.33% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 million, marking a year-over-year increase of 3755.2%. This contributed to the annual value of $9.6 million for FY2024, which is 1433.94% down from last year.
  • Per Palisade Bio's latest filing, its Cash from Financing Activities stood at $3.4 million for Q3 2025, which was up 196833.33% from $4000.0 recorded in Q2 2025.
  • Palisade Bio's 5-year Cash from Financing Activities high stood at $12.0 million for Q3 2022, and its period low was -$258000.0 during Q1 2025.
  • For the 5-year period, Palisade Bio's Cash from Financing Activities averaged around $2.5 million, with its median value being $1.6 million (2022).
  • In the last 5 years, Palisade Bio's Cash from Financing Activities surged by 520344.83% in 2023 and then tumbled by 11274.7% in 2025.
  • Palisade Bio's Cash from Financing Activities (Quarter) stood at $1.2 million in 2021, then surged by 48.78% to $1.7 million in 2022, then crashed by 107.82% to -$134000.0 in 2023, then surged by 3205.97% to $4.2 million in 2024, then fell by 19.2% to $3.4 million in 2025.
  • Its last three reported values are $3.4 million in Q3 2025, $4000.0 for Q2 2025, and -$258000.0 during Q1 2025.